These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1190 related items for PubMed ID: 9692396

  • 21. Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide.
    Hilbert L, Nurden P, Caron C, Nurden AT, Goudemand J, Meyer D, Fressinaud E, Mazurier C, INSERM Network on Molecular Abnormalities in von Willebrand Disease.
    Thromb Haemost; 2006 Sep; 96(3):290-4. PubMed ID: 16953269
    [Abstract] [Full Text] [Related]

  • 22. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M.
    Acta Haematol; 2009 Sep; 121(2-3):102-5. PubMed ID: 19506355
    [Abstract] [Full Text] [Related]

  • 23. The Lesson Learned from the New c.2547-1G > T Mutation Combined with p.R854Q: When a Type 2N Mutation Reveals a Quantitative von Willebrand Factor Defect.
    Casonato A, Cozzi MR, Ferrari S, Rubin B, Gianesello L, De Marco L, Daidone V.
    Thromb Haemost; 2022 Sep; 122(9):1479-1485. PubMed ID: 35189660
    [Abstract] [Full Text] [Related]

  • 24. Next-generation sequencing of von Willebrand factor and coagulation factor VIII genes: a cross-sectional study in Croatian adult patients diagnosed with von Willebrand disease.
    Lapić I, Radić Antolic M, Boban A, Coen Herak D, Rogić D, Zadro R.
    Croat Med J; 2022 Apr 30; 63(2):166-175. PubMed ID: 35505650
    [Abstract] [Full Text] [Related]

  • 25. Laboratory Testing for von Willebrand Factor: Factor VIII Binding (for 2N VWD).
    Mohammed S, Favaloro EJ.
    Methods Mol Biol; 2017 Apr 30; 1646():461-472. PubMed ID: 28804848
    [Abstract] [Full Text] [Related]

  • 26.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Johnsen J.
    ; 1993 Apr 30. PubMed ID: 20301765
    [Abstract] [Full Text] [Related]

  • 27. Molecular genetics of type 2 von Willebrand disease.
    Fressinaud E, Mazurier C, Meyer D.
    Int J Hematol; 2002 Jan 30; 75(1):9-18. PubMed ID: 11843298
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of an automated screening assay for von Willebrand disease type 2N.
    Taylor SL, Bromidge E, Savidge GF, Alhaq A.
    Clin Lab Haematol; 2002 Dec 30; 24(6):369-75. PubMed ID: 12452818
    [Abstract] [Full Text] [Related]

  • 29. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.
    Acta Haematol; 2009 Dec 30; 121(2-3):71-84. PubMed ID: 19506352
    [Abstract] [Full Text] [Related]

  • 30. Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease.
    Biguzzi E, Siboni SM, le Cessie S, Baronciani L, Rosendaal FR, van Hylckama Vlieg A, Peyvandi F.
    J Thromb Haemost; 2021 Jan 30; 19(1):96-106. PubMed ID: 32998182
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical phenotype in genetically confirmed von Willebrand disease type 2N patients reflects a haemophilia A phenotype.
    van Meegeren ME, Mancini TL, Schoormans SC, van Haren BJ, van Duren C, Diekstra A, Laros-van Gorkom BA, Brons PP, Simons A, Hoefsloot L, van Heerde WL.
    Haemophilia; 2015 Sep 30; 21(5):e375-83. PubMed ID: 26207643
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Type 2N von Willebrand disease.
    Mazurier C, Hilbert L.
    Curr Hematol Rep; 2005 Sep 30; 4(5):350-8. PubMed ID: 16131435
    [Abstract] [Full Text] [Related]

  • 36. The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy.
    Delbrück C, Miesbach W.
    Acta Haematol; 2019 Sep 30; 142(2):71-78. PubMed ID: 31085919
    [Abstract] [Full Text] [Related]

  • 37. Type 2N VWD: Conclusions from the Spanish PCM-EVW-ES project.
    Pérez-Rodríguez A, Batlle J, Pinto JC, Corrales I, Borràs N, Garcia-Martínez I, Cid AR, Bonanad S, Parra R, Mingot-Castellano ME, Navarro N, Altisent C, Pérez-Montes R, Moretó A, Herrero S, Soto I, Mosteirín NF, Jiménez-Yuste V, Jacob AA, Fontanes E, Mateo J, Quismondo NC, Batlle F, Vidal F, López-Fernández MF, investigators and centers involved in the PCM-EVW-ES projectComplexo Hospitalario Universitario A Coruña, INIBIC, A Coruña, Spain..
    Haemophilia; 2021 Nov 30; 27(6):1007-1021. PubMed ID: 34494337
    [Abstract] [Full Text] [Related]

  • 38. Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys.
    Federici AB.
    Blood Coagul Fibrinolysis; 2005 Apr 30; 16 Suppl 1():S17-21. PubMed ID: 15849522
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A new method measuring the interaction between von Willebrand factor and coagulation factor VIII.
    Karlman M, Holmström M, Wiman B.
    Thromb Res; 2011 Jan 30; 127(1):47-50. PubMed ID: 21094987
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 60.